Abstract
Bone disease in multiple myeloma results from uncoupled osteoclast and osteoblast activity. Osteoblasts or bone forming cells show impaired differentiation, increased apoptosis and overall reduced function. Soluble and membrane bound proteins have been studied for their role in myeloma-related osteoblast inhibition. Progress in the understanding of the pathogenesis of the osteoblast axis in myeloma has allowed the development of novel targeted therapies, such as DKK1 and activin inhibitors. This chapter provides an overview of the mechanisms behind osteoblast inhibition in myeloma and novel anabolic agents under clinical investigation.
| Originalsprache | Englisch |
|---|---|
| Titel | Basic Science |
| Herausgeber (Verlag) | Springer New York |
| Seiten | 203-214 |
| Seitenumfang | 12 |
| Band | 1 |
| ISBN (elektronisch) | 9781461446668 |
| ISBN (Print) | 1461446651, 9781461446651 |
| DOIs | |
| Publikationsstatus | Veröffentlicht - 01 Mai 2013 |
| Extern publiziert | Ja |
ASJC Scopus Sachgebiete
- Allgemeine Medizin
Fingerprint
Untersuchen Sie die Forschungsthemen von „Role of osteoblast in myeloma pathology“. Zusammen bilden sie einen einzigartigen Fingerprint.Dieses zitieren
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver